Emily Keung, MD, FACS

Dr. Keung is a sarcoma surgeon-scientist who leads a basic and translational research program and laboratory that focuses on studying tumor and immune-mediated mechanisms of response and resistance to immunotherapy, identifying predictive biomarkers of therapeutic response in soft tissue sarcoma, and discovering novel therapeutic targets and strategies to prevent tumor recurrence and to enhance the efficacy of immune-based therapies for patients with soft tissue sarcoma. Dr. Keung received her undergraduate degree from Harvard College and her medical degree from Harvard Medical School. She completed her general surgery residency and surgical critical care fellowship at Brigham and Women's Hospital and fellowship in Complex General Surgical Oncology at MD Anderson Cancer Center. She is a member of the MD Anderson Physician Scientist Program and the National Cancer Institute’s Early-Stage Surgeon Scientist Program (ESSP) and is a past recipient of a Sarcoma Foundation of America Research Award, Society for Immunotherapy of Cancer Steven A. Rosenberg Scholar Award, and Society of Surgical Oncology Young Investigator Award. She is also currently serving as Vice Chair of Research in the Department of Surgical Oncology at MD Anderson Cancer Center.

Disclosures:

• Employment: The University of Texas MD Anderson Cancer Center:Assistant professor:Employee
• Compensation: UpToDate: Other, Compensation Payment-End Date: To Present
• Ownership: none
• Leadership: none